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Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear
internalization and large areas of myofibrillar disorganization
Aims: To report the clinical, pathological and genetic
findings in a group of patients with a previously not
described phenotype of congenital myopathy due to
recessive mutations in the gene encoding the type 1
muscle ryanodine receptor channel (RYR1). Methods:
Seven unrelated patients shared a predominant axial and
proximal weakness of varying severity, with onset during
the neonatal period, associated with bilateral ptosis and
ophthalmoparesis, and unusual muscle biopsy features
at light and electron microscopic levels. Results: Muscle
biopsy histochemistry revealed a peculiar morphological
pattern characterized by numerous internalized myonu-
clei in up to 51% of fibres and large areas of myofibrillar
disorganization with undefined borders. Ultrastructurally,
such areas frequently occupied the whole myofibre cross
section and extended to a moderate number of sarcom-
eres in length. Molecular genetic investigations identified
recessive mutations in the ryanodine receptor (RYR1)
gene in six compound heterozygous patients and one
homozygous patient. Nine mutations are novel and four
have already been reported either as pathogenic recessive
mutations or as changes affecting a residue associated
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with dominant malignant hyperthermia susceptibility.
Only two mutations were located in the C-terminal trans-
membrane domain whereas the others were distributed
throughout the cytoplasmic region of RyR1. Conclusion:
Our data enlarge the spectrum of RYR1 mutations and
highlight their clinical and morphological heterogeneity.
A congenital myopathy featuring ptosis and external
ophthalmoplegia, concomitant with the novel histo-
pathological phenotype showing fibres with large, poorly
delimited areas of myofibrillar disorganization and inter-
nal nuclei, is highly suggestive of an RYR1-related
congenital myopathy.
Keywords: congenital myopathy, myofibrillar disorganization, nuclear internalization, recessive mutations, RYR1 gene
Introduction
The RYR1 gene (OMIM 180901) encodes the ryanodine
receptor 1, a Ca2+ channel expressed on sarcoplasmic
reticulum membranes at the triad of skeletal muscle
fibres. RyR1 mediates the release of Ca2+ from intracellular
pool in response to nerve stimulation and then plays a
crucial role in excitation–contraction coupling [1]. Muta-
tions of the RYR1 gene cause well-defined forms of con-
genital myopathies, that is, central core disease (CCD;
OMIM 117000) and malignant hyperthermia susceptibil-
ity (MHS; OMIM 145600), an autosomal dominant phar-
macogenetic disease. This gene is also implicated in some
cases identified as multi-minicore disease (MmD; OMIM
602771). The RYR1 mutations associated with CCD are
usually dominant but recessive inheritance has also been
reported, whereas cases identified as MmD are exclusively
linked to recessive mutations [2–7] and recently in
patients with fibre type disproportion as their only patho-
logical feature. [8] Classically in the RYR1 sequence, three
hot-spots are considered, two in the large hydrophilic
domain of RyR1 and one in the C-terminal hydrophobic
domain. Most of the heterozygous dominant CCD muta-
tions are mapped to the C-terminal domain, whereas the
recessive CCD and MmD mutations are more extensively
distributed along the RYR1 sequence. Additionally, a het-
erozygous de novo RYR1 mutation in the C-terminal region
of the protein has been found in a 16-year-old female
patient initially diagnosed with centronuclear myopathy
(CNM) with ‘core-like’ lesions and central nuclei in up to
50% of fibres in the muscle biopsy [9], and a heterozygous
de novo RYR1 mutation in the N-terminal domain has
been found in a patient presented with King-Denborough
syndrome and MHS [10].
In RYR1-related congenital myopathies, the histological
phenotype varies widely. It comprises central and eccen-
tric cores, unique and multiple, structured and unstruc-
tured, well-delimited cores spanning the entire fibre
length or poorly defined cores that spread only a few sar-
comeres, and occasionally a variable degree of sarcomeric
disorganization [2,11–13]. These structural abnormali-
ties are sometimes associated with an increased number of
internal myonuclei (up to 30% of the fibres) and variable
degrees of fibrous and adipose tissue replacement
[6,14,15]. There also exist biopsies without major alter-
ations showing only a type I fibre predominance or unifor-
mity [16]. Moreover, a histopathological continuum has
been suggested linking the diverse RYR1-related core myo-
pathies [17–20]. On the other hand, centronuclear myo-
pathies (CNM; OMIM 310400, 160150 and 255200),
comprise X-linked recessive, autosomal dominant and
autosomal recessive forms, associated, respectively, with
myotubularin 1 (MTM1), dynamin 2 (DNM2) and amph-
iphysin 2 (BIN1) genes [21–23]. The histopathological
presentation of these distinct forms of CNM has been well
established [24]; so far, neither cores nor minicores have
been described in such genetically determined CNM forms.
Here we report clinical, histological and molecular
characterization of seven patients initially diagnosed with
CNM due to the significantly high number of fibres with
internalized nuclei (up to 51% of the fibres). However, the
key histopathological feature that led us to screen RYR1
gene for mutations was the invariable presence of large
areas of sarcomeric disorganization in the muscle fibres,
despite the number and location of internalized nuclei.
Thus, RYR1 recessive mutations were found in every
patient of the series demonstrating that this peculiar




We retrospectively reviewed the clinical and histological
data of patients with an original diagnosis of CNM
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without DNM2 mutations. We identified seven unrelated
patients (five women and two men) (Table 1) who shared
the same morphological findings in the muscle biopsy (see
Results). This study was authorized by the ethical commit-
tee of Pitié-Salpêtrière Hospital (CCPPRB) and the Direc-
tion de Recherché Clinique of the Assistance Publique,
Hôspitaux de Paris.
Histopathological studies
Skeletal muscle biopsies were obtained from all patients.
Age of patient and the biopsied muscles were indicated in
Table 1. Histological, histoenzymological and electron
microscopic analyses were performed as previously
described [25]. Ultrastructural studies were performed in
all patients except patient 2. The number of fibres with
nuclear centralization (that is, myonuclei in the geometric
centre of the fibre) and with nuclear internalization (that
is, myonuclei underneath the sarcolemma anywhere
within the cytoplasm) were counted in a minimum of 200
adjacent muscle fibres. In each biopsy, the diameter of
type 1 and type 2 fibres stained with myosin adenosine
triphosphatase (ATPase) 9.4 was measured manually on
digital pictures in at least 120 fibres using ImageJ 1.40g®
(NIH, Washington, USA).
Molecular genetics studies
Informed consent for genetic analysis was obtained from
each patient and their families. RYR1 mutation screening
was performed on cDNA obtained after reverse transcrip-
tion of total RNA extracted from muscle specimens as
previously described [2]. The cDNA was amplified in over-
lapping fragments. Sequencing reactions were analysed
on an ABI 3130 DNA Analyzer (Life Technologies, Foster
City, CA, USA). The presence of the mutations identified in
transcripts was confirmed in genomic DNA by direct
sequencing of the corresponding exon and intron–exon
junctions. None of the novel variants was found in 200
chromosomes from the general population. To evaluate
the consequences of the c.8692+131G>A mutation at the
transcription level, cDNA fragments encompassing exons
56 and 57 were amplified and cloned using the TOPO TA
Cloning® Kit (Invitrogen, Carlsbad, CA,USA). After trans-
formation into One Shot Competent DH5a™-T1R cells
(Invitrogen), colonies containing the recombinant plas-
mids were identified by PCR using RYR1 specific primers,
and the cDNA inserts were sequenced.
Protein analysis
To analyse the expression of RyR1, thin slices of frozen
muscle biopsies from patients 1 and 6 were homogenized
in Hepes 20 mM (pH 7.4), sucrose 200 mM, CaCl2
0.4 mM, Complete Protease Inhibitor® cocktail (Roche,
Meylan, France). The amount of RyR1 present in each
muscle sample was determined by quantitative Western
blot analysis using antibodies directed against RyR1 as
described previously [26]. Signals were detected using a
chemiluminescent horseradish peroxidase (HRP) sub-
strate and quantified using a ChemiDoc XRS apparatus




The parents of the seven patients were clinically unaf-
fected. All patients except patient 6 were born from
non-consanguineous families. Patient 1 was the second
daughter of a family with two affected and two non-
affected children, and her eldest affected sister died at 5
months of age due to severe respiratory impairment and
weakness; all the other patients were sporadic cases. Pre-
natal symptoms were noted only in patient 2 with reduced
foetal movements. At birth, the seven patients showed
generalized hypotonia, poor spontaneous movements and
amyotrophy, together with weak suction and swallowing
difficulties. Motor development was delayed in all patients.
Poor head control was noted in patients 1 and 2, who
required support to sit or walk. Since early childhood,
patients showed difficulties in rising up from the floor,
climbing stairs and running. Patients progressively
improved their motor capabilities and have acquired inde-
pendent ambulation with the exception of patient 1.
Significant facial involvement (hypomimia, open mouth,
facial diplegia and elongated facies) was observed particu-
larly in patients 1 and 2, and at a moderate level in the
other patients. All patients showed some degrees of ocular
involvement consisting of either ptosis or ophthalmopare-
sis with limited upward gaze or incomplete eyelid closure.
Serum creatine kinase levels were normal or slightly
increased. A computed tomography (CT) scan performed
to patient 3 showed a discrete symmetric involvement of
deltoids and deep muscles of the pelvic girdle, thigh and
leg. In patient 4 a CT scan performed at 34 years old
Recessive RYR1-related congenital myopathy 273
© 2011 The Authors





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































274 J. A. Bevilacqua et al.
© 2011 The Authors
Neuropathology and Applied Neurobiology © 2011 British Neuropathological Society, 37, 271–284
showed a diffuse hypodensity, mainly in the tight and
hamstring muscles (Figure 1). Respiratory function was
severely affected in patients 1 and 2 early in life but
improved slightly; their vital capacities in adolescence or
adulthood were, respectively, 35% and 28% of the theo-
retical value (restrictive respiratory syndrome), requiring
non-invasive respiratory support. Vital capacities in
patients 4 and 6 were 50% and 65% of the theoretical
value. Cardiac assessment was normal in all patients.
Morphological studies
Histoenzymological analyses have demonstrated a con-
spicuous and reliable morphological pattern on trans-
verse muscle cryostat sections consisting of: (i) Large
and weakly defined areas devoid of ATPase and oxidative
activities observed in some fibres, sometimes covering the
majority of the fibre diameter (Figures 2b,f,j and 3g).
Such areas were identified as regions of myofibrillar and
sarcomeric disorganization, either showing an absence
or increased oxidative reactivity (Figures 2c,g,k and 3f).
(ii) Several fibres displayed a peculiar ‘purple dusty’
appearance with Gomori trichrome staining, due to a
precipitate of numerous small fuchsinophilic particles
spreading partially or completely through the fibre cross
section (Figures 2d,h,l and 3d,h). These extensive areas
of fuzzy reddish aggregates were also evident on haema-
toxylin and eosin stained serial sections (Figures 2a,e,i
and 3e), corresponding with the zones of abnormal
staining on oxidative reactions (Figures 2c,g,k and 3f)
and they also lacked ATPase activity (Figures 2b,f,j and
3g). (iii) Type I predominance or type I fibre uniformity
and increased variability in fibre size; and (iv) Nuclear
internalization and centralization in both fibre types,
including frequent multiple internalized nuclei. In addi-
tion, a discrete increase of endomysial connective tissue
was often observed.
Noticeably, the muscle biopsies performed at the ages
of 4 months for patient 1 and 21 months for patient 2,
essentially showed type I fibre predominance, increased
endomysial connective tissue, significant variation in
type I or II fibre size and the presence of some small fibres
with central nuclei resembling myotubes. No cores were
observed. Thereafter, the muscle biopsies performed at
the ages of 12 and 14 years for patient 1 and 12 years for
patient 2 showed the peculiar morphological pattern
observed in all patients. Nuclear internalization increased
with age (Table 1; Figure 3).
Ultrastructural findings
In patients 1 and 3 to 7, ultrastructural analysis of muscle
biopsies in longitudinal sections demonstrated large areas
Figure 1. Computed tomography limb imaging of patient 4. Upper
and lower limb computed tomography scanner from patient 4 (a to
e) at the age of 34. Axial sections were performed at middle level of
the arms (a, b), pelvic girdle (c), upper tight (d) and legs (e). In the
arms and pelvic girdle, diffuse atrophy of the muscles is observed
without any particular pattern. In the tights (d), fatty infiltration is
seen in adductor magnus, semimembranosus, semitendinosus and
biceps femoris, with a relative sparing of gracilis, sartorious and
anterolateral compartment muscles. In the legs (e), hypodensity of
the imaging is prominent in the internal gastrocnemius of the
posterior compartment, with a relative normal signal in the other
muscle.
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of sarcomeric disorganization (Figure 4d). Such areas
were present in one or more regions within a fibre, were
variable in width and length, frequently covered the
entire fibre diameter in cross section (Figures 4a,b) and
extended from 2 to 30 sarcomeres in longitudinal
sections (Figures 4b,f). Altered fibres often showed one or
several misplaced nuclei that were occasionally found
at the border of areas of myofibrillar disorganization
(Figures 4b,d). Within such disorganized areas, accumu-
lation of Z-band proteins, Z-band streaming, enlarged
Z-bands and myofibrillar compaction were the most
frequent alterations (Figures 4c,e). T-triads-repetitions,
honeycomb profiles (corresponding to T-tubules prolifera-
tions) and occasional minicore-like lesions (Figure 4f)
were also observed amongst other non-specific alter-
ations. Mitochondria were present or not in the disorga-
nized areas.
Immunohistochemical findings
In order to further study the composition of the disorga-
nized intracellular areas, biopsies of patients 2, 3 and 5
were labelled with antibodies to the intermediate filament
proteins desmin, aB-crystalline and myotilin. The three
markers intensively labelled the disorganized areas, but in
serial sections reacting fibres were either labelled with one,
two or three of the antibodies used, suggesting a hetero-
geneous composition of the disorganized zones (Figure 5).
RYR1 screening
Patient 1 and her deceased sister were c.[10348-6C>G;
14524G>A] + c.[8342_8343delTA] compound heterozy-
gous carriers (Table 2). The c.8342_8343delTA frame-
shift deletion transmitted by the clinically unaffected
Figure 2. Light microscopy of muscle sections. Transverse serial sections of muscle biopsies from patient 4 (a to d), Patient 2 (e to h) and
patient 5 (i to l) stained with haematoxylin and eosin (a, e, i), ATPase 9.4 (b, f, j), nicotinamide adenosine dinucleotide–tetrazolium
reductase (NADH-TR) (c, g, k) and Gomori trichrome (d, h, l). Note with haematoxylin and eosin staining the great variability in fibre size;
misplaced nuclei and multiple internalized nuclei are observed in many fibres along with increase in endomysial tissue. NADH-TR staining
shows unevenness in the sarcoplasmic and mitochondrial distribution. Type I fibre predominance or uniformity is observed in all cases and
some fibres show poorly delimited areas devoid of ATPase 9.4 reaction, which correspond to areas presenting sarcomeric disorganization
with increased or absence of oxidative reaction. The same fibres contain the purple dusty areas with Gomori trichrome staining described
in the text. Note that the two top rows show pictures at ¥ 400 magnification, while the bottom row pictures are at ¥ 200 magnification.
(See Table 1 for details on the diameter of fibres in each case.) Scale bars: in h = 50 mm, for a to h; and in l = 100 mm, for i to l.
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mother introduced a premature stop codon
(p.Ile2781ArgfsX49). The two other variants were inher-
ited from the clinically unaffected father. The c.10348-
6C>G change resulted in a loss of splicing of intron 68
and the introduction of a premature stop codon
(p.His3449ins33fsX54). Both unspliced and spliced
transcripts were present, thus indicating an incomplete
penetrance of this intronic variation. The c.14524G>A
change in exon 101 resulted in a p.Val4842Met substitu-
tion that mapped to the M8 trans-membrane fragment of
the Ca2+ pore domain [27]. RyR1 expression analysis did
not show truncated proteins but instead a major decrease
of the mature protein, indicating the residual presence of
a low amount (15  8%) of mutated Met4842 protein in
the proband’s muscle (Figure 6).
Patient 2 was p.[Thr4709Met] + p.[Glu4181Lys] com-
pound heterozygous. The paternal p.Thr4709Met substi-
tution, resulting from a c.14126C>T change in exon 96
that affected a conserved threonyl residue located in the
Ca2+ pore domain of the protein, has been previously
reported in a case of recessive core myopathy [28]. The
maternal p.Glu4181Lys novel substitution that resulted
from a c.12541G>A transition in exon 90, affected a
highly conserved glutamyl residue located in a cytoplas-
mic domain of unknown function (Table 2).
Patient 3 was compound heterozygous for the novel
p.[Glu4911Lys] and p.[Arg2336Cys] variants. The pater-
nal p.Glu4911Lys (c.14731G>A, exon 102) variant
affected a highly conserved glutamyl residue that mapped
to the M10 trans-membrane fragment of the Ca2+ pore
domain [27]. The maternal p.Arg2336Cys (c.7006C>T,
exon 43) variant also substituted a very well-conserved
arginyl residue located in the MH2 domain of the protein,
usually associated with malignant hyperthermia domi-
nant mutations. However, no anaesthetic history has
been reported in the patient or relatives harbouring the
p.Arg2336Cys variant (Table 2).
Patient 4 was p.[Pro3202Leu] + p.[Gly3521Cys] com-
pound heterozygous. Both variants are novel and substi-
tuted highly conserved residues among species and RYR
isoforms. The paternal p.Pro3202Leu (c.9605C>T, exon
65) variant affected a prolyl residue located in a central
region of the protein of unknown function. The maternal
p.Gly3521Cys (c.10561G>T) variant substituted a glycyl
residue located within exon 71 adjacent to the alterna-
tively spliced region I (ASI), possibly involved in interdo-
main interaction (Table 2) [29].
Patient 5 was p.[Pro3138Leu] + p.[Arg3772Trp]
compound heterozygous. The paternal p.Pro3138Leu
(c.9413C>T) variant affected a highly conserved prolyl
Figure 3. Evolution of histopathological findings in patient 2. Transverse serial sections of muscle biopsies from patient 2 at 21 months
(a to d), and at 12 years of age (e to h) stained with haematoxylin and eosin (a, e), nicotinamide adenosine dinucleotide–tetrazolium
reductase (NADH-TR) (b, f), ATPase 9.4 (c, g) and Gomori trichrome (d, h). Note with haematoxylin and eosin increase in fibre size, number
of internalized nuclei and hyaline cytoplasmic protein aggregates. With NADH-TR staining the unevenness in the sarcoplasmic and
mitochondrial distribution is recognized in the biopsy at 12 years but was not evident in the firs biopsy. With ATPase 9.4 the type I fibre
predominance seen in the first biopsy changes to a type I uniformity and the number of fibres with areas devoid of ATPase 9.4 reaction
increase in number and the areas are more conspicuous. Similar increase in the features described is seen with Gomori trichrome. (See also
Table 1 for details on the diameter of fibres in each case.) Scale bar = 50 mm.
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residue that mapped to exon 63. This variant has not
been reported previously. The maternal p.Arg3772Trp
(c.11314C>T, exon 79) variant has been recently reported
in an MHS patient [30]. The mutation substituted a highly
conserved argininyl residue into a nonconservative tryp-
tophan located in a cytoplasmic domain of unknown
function (Table 2).
Analysis of patient 6’s cDNA revealed the presence of
two abnormal transcripts characterized by insertions of
132 bp and 32 bp between exons 56 and 57, and the
presence of a normally spliced transcript. Genomic
sequencing of intron 56 identified a homozygous
c.8692+131G>A change, which revealed a cryptic donor
splice site in competition with the physiological splice site
(Table 2). Use of this cryptic splice site led mostly to an
insertion of 132 bp that introduced 44 amino acids
and a premature stop codon between exons 56 and 57
(p.Gly2898GlyfsX36). In addition, the presence of another
putative AG dinucleotide splice acceptor site upstream to
the cryptic donor splice site, led to an additional alternative
frameshift insertion of 32 nucleotides, also leading to a
premature stop codon (p.Gly2898AspfsX54) (Figure 7a).
However, no truncated proteins were detected on Western
blot analysis, suggesting either instability of the cryptic
transcripts as a result of a nonsense-mediated mRNA
decay process or an early degradation of the truncated
proteins as a result of an unfolded protein response. The
residual physiological splicing allowed the production of a
low amount of wild-type RyR1 (22  12%) in the muscle
of the patient (Figure 6).
Patient 7 was p.[Pro3202Leu] + p.[Arg4179His]
compound heterozygous. The maternal p.Pro3202Leu
(c.9605C>T, exon 65) variant was recurrent in this study
(patient 4). The paternal p.Arg4179His (c.12536G>A,
exon 90) variant affected a highly conserved arginyl
residue that mapped to a cytoplasmic domain of the
protein close to the p.Glu4181Lys variant identified in
patient 2.
Discussion
We have identified a cohort of seven patients with con-
genital myopathy and a peculiar morphological pattern in
muscle biopsies associated with recessive mutations in the
gene encoding the skeletal muscle ryanodine receptor
(RYR1). All the patients showed early onset of the disease,
ophthalmoparesis of variable severity and presence of
early disabling contractures, especially in the masticators.
Rigid spine syndrome was also present in two patients.
Otherwise clinical presentation was similar to most con-
genital myopathies, showing hypotonia of variable sever-
ity, delay in the acquisition of developmental motor
Figure 4. Ultrastructural findings in muscle fibres from patients. Electron microphotographs of myofibres from patient 4 (a), patient 6 (b),
patient 5 (c, d, e) and patient 3 (f) show different ultrastructural alterations. Transverse and longitudinal muscle sections are shown in left
and right panels, respectively. The lesions cover most of the cross section of affected fibres and are adjacent to internalized nuclei (a, b). The
areas of myofibrillar disorganization contain Z band proteins aggregates (c, e). The box framed in c is depicted at higher magnification in e.
Two misplaced nuclei are near the border of an area of myofibrillar disorganization, which continues from normally appearing sarcomeres
(d). Triad repetitions are seen within a small zone of Z disc streaming (f). Scale bars in a and e = 2 mm, b and c = 10 mm, d = 4 mm and
f = 5 mm.
Figure 5. Muscle biopsy immunostaining. Serial sections immunostained with antibodies to desmin (a), aB-crystalline (b) and myotilin (c)
showed positive staining for all the markers used. In some cells labelling was similar with the three markers (1); in other, reaction was
positive for desmin and aB-crystalline but not myotilin (2), and in a third set of fibres labelling was somehow stronger for myotilin (3), whilst
in a fourth group of fibres labelling was stronger for aB-crystalline (4). Scale bar in c = 30 mm.
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milestones, axial and proximal limb weakness and restric-
tive respiratory syndrome. Cardiac and cognitive func-
tions were invariably spared.
Our data enlarges the histological phenotype associated
with RYR1 mutations. Indeed, the areas of sarcomeric/
myofibrillar disorganization are distinguishable from
typical cores. On oxidative stains, these areas are large,
diffuse and poorly delimited. Ultrastructurally, they are
broader than cores in transverse sections, as they fre-
quently cover extensive cross-sectional areas of the fibre,
often reaching the sarcolemma. They are also shorter
than cores, as in longitudinal sections they extend along a
relatively small number of sarcomeres. In contrast with
cores the presence of mitochondria within the lesions
accounts for the excessive oxidative staining in some
fibres. On the other hand, ‘purple dusty areas’ correspond-
ing to foci of Z line rearrangements are not usually seen in
muscle biopsies of patients with classical core myopathies.
Interestingly, the first descriptions of congenital myopa-
thies with ‘target-like fibres’ as described by Schotland in
the 1960s, reported morphological findings close to those
described in our patients; retrospectively, these similarities
might provide the molecular cause for these earlier
observations [31,32].
Moreover, in our series of patients, nuclear misplace-
ment affected up to 51% of the fibres. Remarkably, fibres
with centralized nuclei ranged from 1 to 9%, while
nuclear internalizations were present in up to 47% of the






































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6. Western blots analysis of muscle biopsy. Forty
micrograms (40 mg) of muscle homogenate from control (C),
patient 1 (P1) or patient 6 (P6) have been loaded on a 5–15%
acrylamide gel, and after electrotransfert to Immobilon-P, the blot
has been incubated with an anti-RyR antibody (Marty et al. [26])
which cross react with the full length protein (the higher molecular
weight band in the control) and the degradation fragments (the
lower molecular weight bands in the control). Only the full length
protein is detected in both patient biopsy, which represent
22%  12% (P6) and 15%  8% (P1), respectively, of the control.
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internalized nuclei (Table 1). This contrasts with what is
usually observed in DNM2-, BIN1- and neonatal MTM1-
related CNM, where fibres with centralized nuclei clearly
outnumber fibres with internalized nuclei [24]. In addi-
tion, in this set of recessive RYR1-related patients, inter-
nalized nuclei are frequently multiple, and are randomly
dispersed into the sarcoplasm. As we have stressed in pre-
vious reports [24,25,33] and confirmed in the present
study, the location of misplaced nuclei (that is, central,
random, unique, multiple) is a relevant clue to orientate
molecular diagnosis.
Interestingly, a pathophysiological link has been sug-
gested between RYR1 and CNM based on the study of a
MTM1 knock out mice, which presented reduced levels of
RyR1 protein and defects in excitation–contraction cou-
pling [34]. We assessed MTM1 protein content in muscles
from our recessive RYR1-related patients but no variation
was found with respect to control samples (data not
shown).
As the areas of myofibrillar disorganization described
here in some muscle fibres appear to lack ATPase and
oxidative activities, such structural rearrangements could
be mistakenly interpreted as similar to the ‘rubbed-out
fibres’ usually observed in myofibrillar myopathies, there-
fore suggesting a pathological overlap between the two
myopathies. However, the structural alterations are differ-
ent especially at the ultrastructural level [24,35]. In
addition, the clinical, muscle imaging and pathological
context of patients should be considered in the differential
diagnosis.
The notion that histoarchitectural changes in congeni-
tal myopathies evolve according to age is not novel.
Figure 7. Schema relating to mutations found in patient 6 and summary of RYR1 mutations. (a) Consequences of the homozygous
c.8692+131G>A mutation in RYR1 intron 56 identified in patient 6. (b) Mapping of the missense mutation in RYR1. MH1 and MH2, hot
spots for mutations associated with malignant hyperthermia (MH) susceptibility; TM, transmembrane domains; CaM, calmodulin; 4-CmC,
4-chlorocresol. Seven missense variants were novel (p.Arg2336Cys, p.Pro3138Leu, p.Pro3202Leu, p.Gly3521Cys, p.Arg4179His,
p.Glu4181Lys, p.Glu4911Lys); the p.Pro3202Leu variant found in two unrelated patients in this study (patients 4 and 7).
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Several reports have addressed the topic, both before and
during the molecular genetics era [9,17,20,36,37].
However, the marked alterations described in the biopsies
of patients 1 and 2 of this series deserve a special consid-
eration, as they may lead to an inappropriate diagnosis.
Thereby, after the first years of life, the pattern of alter-
ations evolved towards those of a congenital myopathy
(that is, type I predominance and hypotrophy, type I uni-
formity, low percentage of internalized nuclei), to finally
consolidate during the second half of the first decade, into
the typical pattern of alterations described herein (core-
like lesions, purple dusty fibres, multiple internalized
nuclei) (Figure 3). Such considerations are of great
relevance for the pathological differential diagnosis.
However, the histological hallmark in these cases was the
presence of the unclearly delimited areas of myofibrillar
disorganization observed with oxidative and ATPase tech-
niques. These alterations, which were less conspicuous
and affected fewer fibres in younger patients, were none-
theless the right clue to direct molecular testing.
Our data significantly enlarges also the spectrum of
RYR1 mutations since; among the 13 variants identified,
nine are novel (Table 2 and Figure 7b). Compound het-
erozygous mutations were identified in six unrelated
patients and a homozygous mutation in patient 6. Com-
pound missense mutations were present in five patients
while amorphic/hypomorphic mutations leading to RyR1
depletion were found in two patients (patients 1 and 5).
In six patients recessive inheritance was confirmed by
familial studies. In patient 6 for whom parental samples
were not available, familial consanguinity, homozygosity
of the mutation and the absence of familial history were
strongly suggestive of a recessive inheritance.
Seven missense variants were novel. All of them were
absent in 200 unrelated controls and affected highly con-
served residues. The p.Thr4709Met variant has been
already reported in a recessive form of core myopathy [28]
while the p.Arg3772Trp change has been identified as the
single change in RYR1 in an MHS patient [30]. This last
variant, which is clearly recessive with respect to the
myopathy, could confer dominant MHS susceptibility. This
could be also the case of the p.Arg2336Cys variant that
mapped to the MH2 domain of the protein, a hot spot for
malignant hyperthermia mutations, and whose position
has already been involved in a malignant hyperthermia-
causing mutation (Arg2336His) [30]. Most of the vari-
ants present in this study were located in the cytoplasmic
region spanning from the MH2 domain to the Ca2+ pore
domain whose functions remain mostly unknown.
Moreover, the pathophysiological pathways associated
with recessive missense mutations in RYR1 are generally
unknown and are likely to be mutation specific [38]. No
malignant hyperthermia reactions were documented in
these patients or among their relatives; however, in vitro
contracture testing was not carried out in this series. Nev-
ertheless, awareness about the potential risk of MHS is
advisable before affected patients or their possible carrier
relatives.
Patient 1 was compound heterozygous for a null muta-
tion (c.8342_8343delTA) on one allele and for a hypo-
morphic splicing mutation (c.10348-6C>G) associated
with a missense variant (p.Val4842Met) on the second
allele. Only a low amount of Met4842 mutant RyR1
protein was detected in muscle biopsy. Interestingly, a
low amount of Met4842-RyR1 protein has previously
been observed in two affected sisters who were com-
pound heterozygous for the same missense and other
null mutations [c.10348-6C>G, p.Val4842Met] and a
c.7324-1G>T [19]. They also presented a severe neonatal
form of congenital myopathy. In contrast, patient 6 was
homozygous for the hypomorphic c.8692+131G>A
mutation. The severity of his disease was relatively mod-
erate despite the low amount of RyR1 expressed in the
muscle, but it should be noted however that the residual
expression corresponded to the wild-type RyR1 protein in
this patient. Altogether these data suggest that RyR1
depletion in skeletal muscle is one of the pathophysi-
ological mechanisms of the disease as already reported
in recessive forms of RYR1-related congenital myopathy
[19,28,38–40].
In conclusion, we have identified a specific clinical and
histological phenotype associated with recessive RYR1
mutations. Our data clearly show that in this group of
patients, the histological phenotype shares features tradi-
tionally described in different forms of congenital myopa-
thies, namely centronuclear and core myopathies. They
strongly support the idea that the presence of disorganized
myofibrillar areas with irregular borders in muscle biop-
sies from patients with clinical manifestations of congeni-
tal myopathy are likely to be due to RYR1 mutations, even
in the presence of numerous fibres with internalized
nuclei. Hence, this peculiar morphological pattern should
be consistently associated with the subgroup of ‘congeni-
tal myopathies with cores’. This will improve molecular
diagnosis and consequently, genetic counselling and the
prognosis given to patients.
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